Table 3 Adverse drug events observed during the 28-day follow-up
AE | Follow-up days and Number (Frequency*) of AEs (N = 88), n (%) | Total n (%) | |||||||
|---|---|---|---|---|---|---|---|---|---|
| Â | Day-0 | Day-1 | Day-2 | Day-3 | Day-7 | Day-14 | Day-21 | Day-28 | Â |
Headache | – | 5 (5.7) | 2 (2.3) | – | – | – | – | – | 7 (8) |
Anorexia | – | 3 (3.4) | 2 (2.3) | – | – | – | – | – | 5 (5.7) |
Nausea | 2 (2.3) | 4 (4.5) | – | – | – | – | – | – | 6 (6.8) |
Vomiting | 2 (2.3) | 2 (2.3) | – | – | – | – | – | – | 4 (4.5) |
Abdominal pain | – | – | – | 1 (1.1) | – | – | – | – | 1 (1.1) |
Diarrhoea | – | – | 1 (1.1) | 1 (1.1) | 1 (1.1) | – | – | – | 3 (3.4) |
Cough | – | – | 1 (1.1) | 1 (1.1) | 1 (1.1) | – | – | – | 3 (3.4) |
Dizziness | – | – | – | 1 (1.1) | 1 (1.1) | – | – | – | 2 (2.3) |
Joint pain | – | – | – | – | – | 1 (1.1) | – | – | 1 (1.1) |
Itching | – | – | – | – | – | – | 1 (1.1) | – | 1 (1.1) |
Total n (%) | 4 (4.5) | 14 (15.9) | 6 (6.8) | 4 (4.5) | 3 (3.4) | 1 (1.1) | 1 (1.1) | − | 33 (37.5) |